KTC1101 is an orally bioavailable pan-phosphoinositide 3-kinase (PI3K) inhibitor that suppresses tumor cell proliferation and modulates the tumor microenvironment. It demonstrates anti-tumor activity in preclinical models by inhibiting downstream AKT and mTOR phosphorylation, making it a useful tool for oncology research in both in vitro and in vivo settings.
Molecular Weight:
476.48
Purity:
98.75% (May vary between batches)
CAS Number:
[2764833-47-6]
Formula:
C21H26F2N8O3
Target:
mTOR,Akt,PI3K
Application Notes:
Solubility: DMSO:20 mg/mL (41.97 mM)
* VAT and and shipping costs not included. Errors and price changes excepted
